This order allows public health emergency stakeholders to execute plans for “emergency dispensing of eligible ciprofloxacin products without individual prescriptions in the future if they reasonably believe there is a need to do so because of their constituents’ known, suspected, or likely imminent exposure to B. anthracis.”